2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies
2019 · Journal of Hematology & Oncology · 184 citations
https://doi.org/10.1186/s13045-019-0732-7
H
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
135
Papers
1.7K
Citations
24
h-index
40
i10-index
Haiyan Xing is an academic researcher from Chinese Academy of Medical Sciences & Peking Union Medical College. The author has contributed to research in topics: Acute Myeloid Leukemia Research & CAR-T cell therapy research & Immune Cell Function and Interaction. The author has an h-index of 24, co-authored 115 publications.
Papers by this author
worksActivation of Rac1 GTPase promotes leukemia cell chemotherapy resistance, quiescence and niche interaction
2013 · Molecular Oncology · 38 citations
https://doi.org/10.1016/j.molonc.2013.05.001
A novel CD123-targeted therapeutic peptide loaded by micellar delivery system combats refractory acute myeloid leukemia
2021 · Journal of Hematology & Oncology · 13 citations
https://doi.org/10.1186/s13045-021-01206-y
Low-expression of E-cadherin in leukaemia cells causes loss of homophilic adhesion and promotes cell growth
2011 · Cell Biology International · 12 citations
https://doi.org/10.1042/cbi20100456
Loop33 × 123 CAR-T targeting CD33 and CD123 against immune escape in acute myeloid leukemia
2024 · Cancer Immunology Immunotherapy · 7 citations
https://doi.org/10.1007/s00262-024-03847-7
Identifying ADGRG1 as a specific marker for tumor-reactive T cells in acute myeloid leukemia
2024 · Experimental Hematology and Oncology · 6 citations
https://doi.org/10.1186/s40164-024-00560-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat